A synthetic lethal screening against MYCN-amplified NB revealed that the HDACi vorinostat (also known as SAHA) induces dramatic cell death combined with the proteasome inhibitor bortezomib (BTZ) in part through synergistic activation of BAX. Here, MYCN is linked to neuroblastoma.